Speaker Biographies

David Blair

Head of Industry, Healthcare, Google

David is currently Head of Industry for Healthcare at Google where he and his team drive business transformation with executives at the top pharmaceutical and consumer health companies using data-driven insights, analytics, and machine learning across Google's search, YouTube, Marketing and Cloud platforms. Prior to Google, he was a member of executive leadership teams at Johnson & Johnson's BabyCenter, iVillage.com, Revolution Health, and Everyday Health where he pioneered many of the first digital marketing initiatives across top Fortune 100 companies and brands.

He is a member of the Google Healthcare Advisory Board, was named top 40 Healthcare Transformers in the US by Medical Marketing & Media; serves as a Google Executive Summit Brand Evangelist at the Partnerplex at Google's headquarters in California. David is an industry thought-leader and frequent presenter at major industry summits & conferences including The World Economic Forum on Global Health, IMCAS World Congress, Cannes Lions Health, American Heart Association, Indegene Digital Summit, and the Cleveland Clinic Patient Experience Summit among others.



Chris Boardman

Vice President of Biopharma Solutions, Inmar Intelligence

Chris Boardman is currently Vice President of Biopharma Solutions at Inmar Intelligence. Chris has 30 years of experience in data analytics in the healthcare sector. His career has included working for CDC, Children’s Hospital of Philadelphia, IMS HEALTH, Valuecentric and other companies developing custom data analytic, estimation techniques and services to meet the diverse customer needs.



Nuria Diaz-Tena

Director, Pfizer

Nuria Diaz-Tena joined the Analytics Innovation team at Pfizer as Director and has been responsible for (1) finding innovative methods to assess the sales impact thru engagement metrics, (2) improving digital engagement by optimizing content and frequency, (3) assessing the sales impact of Patient's Digital Initiatives as Social Media and Mobile Apps, (4) computing improvements on drug adherence due to digital wearables campaigns, (5) providing a Mobile App framework to maximize the insights using the mobile app events data, (6) listening what our patients are saying on social media with NLP to help the patients with their treatments.

Before joining Pfizer, Nuria had worked at MarketShare Partners, IMS Health, Inventive Health, TNS-Global and Mathematica Policy Research. She has a PhD in statistics from The University of Pennsylvania (Wharton School) and a bachelor’s in physics from the Autonomous University of Barcelona in Spain.



Brent Erbe

Director, LAAD IQVIA Data, IQVIA

Working in the technology field since 1997, Brent’s primary focus areas include enterprise data warehousing, master data management, business intelligence, advanced analytics, data science, IT strategy and planning, technical team building, SQL Server, Oracle, Netezza, cloud computing, data visualization, user interface architecture, Tableau, and Excel dashboarding.

Brent has worked as a Director of LAAD Patient Data at IQVIA since 2013 where his primary responsibilities include engaging with clients to understand their needs, providing technology and analytics related expertise, and leading a team responsible for mining big data, producing data analytics, building dashboard and reporting solutions, and managing data warehouse infrastructure.

Prior to this, Brent held a similar role at Symphony Health where he worked from 2005 through to 2012. While there, he served as a primary technical architect and helped to build their core patient data asset known as PTD.



John Garcia

Global & US Business Operations Lead, Alnylam

John Garcia is the Global & US Business Operations Lead at Alnylam, a rare disease company focused on the development and commercialization of RNAi based therapeutics. Before Alnylam, John spent his time leading many different commercial teams in biopharma, starting a med device company, and consulting with a host of early stage ventures in life sciences. Prior to John’s life sciences career he was an active duty Marine Officer and retired as a Marine Infantry Major. First, John is a father and husband to his wife of 15 years, Elizabeth, and their four children, Zoe, JT, Gunnar, and Alex. In his free time he goes to work… John holds degrees from Berkeley and the United States Naval Academy and has done coursework at Brown, Stanford, and University of North Carolina.

Daniel Garmat

Senior Analyst, DrFirst

Daniel Garmat is a Senior Analyst at DrFirst based in Rockville, Maryland, focused on medication management. He received his M.S. in Statistics from Oregon State University and B.S. in Business Administration from Carnegie Mellon University. His passions include statistical methods, computation, scalable automation, and the so-called, “Advanced Analytics.”

Most recently, Dan worked in population health analytics for Legacy Health System in Portland, Oregon where he developed predictive models around healthcare utilization and mined prescription data for cost-saving opportunities. He worked daily with healthcare professionals to ensure their needs were met so that analytics solutions integrated cleanly into production clinical workflows.

He has worked in healthcare, manufacturing, and finance, always finding that intersection of data and practical business strategy. He integrates this with an ethical, long term view.

When he is not working, Dan enjoys hiking, ethnobotany, philosophy, and fluid art painting.



Scott Hull

Consultant, Marcus Evans

Scott Hull draws on over 27 years of professional experience in helping organizations evaluate, re-engineer and implement commercial strategies and analytics.

Prior to joining Marcus Evans, Hull was with Shire, where he managed several large engagements across a variety of commercial areas, including sales forces strategy, design, optimization as well as commercial operations, reporting and marketing analytics.

Prior to Shire, Hull worked at J&J, Eli Lilly, CV Therapeutics, Abbott, Hospira and IQVIA in progressive roles such as Sales, HR, Management, Analytics, IC and CRM.

Hull is currently pursuing an MS in Applied Analytics from BU, has an MBA from the Cardinal Stritch University, and a BS Degree from University of WI, PMP and is a Veeva Certified Admin.



Jukti Kalita

Director, Pfizer

Jukti Kalita is a Director of Analytics Innovation (Commercial) team at Pfizer and currently supports its Oncology portfolio (prostate, blood and breast cancer) with advanced analytics like promotional mix modeling, field force targeting and patient level data analytics. In prior roles during his tenure of 7+ years at Pfizer, he supported brands like Viagra, Eliquis, Lyrica and Chantix.

The other institutions where he worked before coming to Pfizer are InVentiv Health (Campbell Alliance and HPR), Merrill Lynch and Baruch College of City University of NY where he was an assistant professor of marketing. He has a PhD from Columbia University, a bachelor’s in engineering from IIT and an MBA degree from IIM in India.



Vanessa Martin

Manager, Advanced Analytics at Janssen Pharmaceuticals, Janssen Pharmaceuticals

Vanessa C. Martin is a Manager of Advanced Analytics at Janssen Pharmaceuticals where she supports the Immunology therapeutic area, turning data into insights and driving strategic decision-making. In her current role, Vanessa leverages an assortment of data sources and analytic tools, and she collaborates with a variety of business partners to answer a diverse set of business questions, ranging from access and fulfillment to patient profiling and physician targeting to adherence and compliance.

Prior to Janssen, Vanessa spent time in pharmaceutical data consulting as a senior methodologist and engagement manager, where she worked across many different therapeutic areas integrating data and building enhanced reporting capabilities. Vanessa has also spent time in the health insurance industry evaluating patient outcomes and financial metrics using advanced statistical modeling techniques.



Sam Roosz

Head of Solutions, Datavant

Sam is a healthcare product veteran with experience in pharma, biotech, and diagnostic companies to bring over 15 products to market. Sam received a degree in Molecular and Cellular Biology from Harvard, and holds an MBA from the Stanford Graduate School of Business.



Jessica Santos

Global Compliance and Quality Director, Kantar Health

Dr. Jessica Santos is the Global Compliance and Quality Director in Kantar, provides consulting and research to communicate the value and potential for products and services that fall under healthcare regulation and legislation. Jessica is providing oversight and support across global offices in regulation, ethics and compliance, and responsible for maintaining, anticipating and coordinating all activities regarding compliance, privacy and quality framework on RWR (Real World Research) and MR (Market Research).

Jessica is also an experienced statistician, analyst and methodologist. She gained her reputation through her publications and professional committee work in the industry. Jessica is a frequent speaker and contributor in major conferences. She has a PhD in Social Science and MRS fellowship.

Jessica is a member of BHBIA and EphMRA code of Ethics Committee, UK Research Ethics Committee, reviewer and chair of ISPOR Code of Conduct Committee.



Michael Venters

Product Director, Symphony Health

Michael Venters is the Managed Markets Product Director for Symphony Health. He has worked for Symphony for ten years in multiple roles, partnering with clients to solve their market access challenges. Prior to Symphony, Michael worked in Pharma for Endo Pharmaceuticals and GlaxoSmithKline. He has a BS in Computer Science from the University of Delaware.



Yunlong Wang

Engagement Manager, Advanced Analytics, IQVIA

Trained as a computer and machine learning scientist, Yunlong has expertise in machine learning, statistical modeling, optimization, simulations, and their applications to spatial temporal data analysis, such as longitudinal claim level data, media impression data, social network, and physician-patient networks. In this capacity, he provides methodological and analytical support to help clients solve complex issues in business and health outcomes research. He leads a team of data scientists and software developers to support various customized projects on healthcare commercial effectiveness and real-world insights solutions, as well as to build machine learning pipelines enhancing delivery efficiency. Prior joining IQVIA, Yunlong was a post-doctoral research fellow in the Digital Technology Center (DTC) at the University of Minnesota. He received his BS degree in electrical engineering from the Xi’an Jiaotong University, and he earned his PhD degree in computer engineering from the State University of New York at Stony Brook. He is an active and prolific scholar whose work has been published more than 20 top journal/ conference papers.



Jonathan Woodring

IPM.ai

Jonathan has spent the last 15+ years of his career building high performing teams and companies in the healthcare and life sciences industries, with a passion for driving commercial innovation in the intersection of data proliferation and technological advancement. At IPM.ai, his team’s current focus is around artificial intelligence and machine learning techniques facilitating positive patient outcomes at scale, with a focus in biotech, rare disease, and Oncology.

As a thought leader in the space, Jonathan is a regular presenter at leading industry conferences—most recently at Healthcare Information and Management Systems Society (HIMSS), as well as at the Pharmaceutical Management Science Association (PMSA) and National Organization for Rare Disease (NORD)—on the topic of leveraging de-identified patient level data and machine learning to identity undiagnosed rare disease patients, and improving healthcare outcomes.



Brian Wynne

Senior Director of Advanced Analytics, Endo Pharmaceuticals

Brian Wynne is currently Senior Director of Advanced Analytics at Endo Pharmaceuticals. Brian has over twenty-five years of experience in data analytics in the pharmaceutical space, building advanced analytic capabilities including promotional response modeling, HCP segmentation and targeting and patient/treatment flow modeling. He has worked for IMS HEALTH and Valuecentric, developing projection methodologies to create new syndicated services. Brian has also managed analytics groups for retail and specialty products at AstraZeneca and Endo. In addition, Brian is an adjunct professor at West Chester University teaching Marketing Analytics for their graduate statistics program.



Li Zhou

Sr. Principle, Advanced Analytics, IQVIA

Li Zhou is the Sr. Principle in the Global advanced analytic team. She has more than 20 years’ experience in the pharmaceutical industry specialized in market science and marketing research. As a Sr. Director of Advanced Analytic group, Li leads a very experienced group with backgrounds in Predictive Analytics with AIML, Projection, Statistics modeling, Marketing Research, and Consulting. This group supports high-end analytic projects, core competence in physician targeting, patient-level studies, and different data assets projections, which integrate pharmacy data, medical, hospital, lab and payer level data. She designed patient projection models for Oncology, RA, HGH and Vaccine data marts. Her other experiences focused on: predictive modeling, survival analysis, forecasting, direct to consumer advertising evaluation, and experimental design. Her strength has been method and product design and development.